Die folgenden Begriffe wurden einbezogen:
antineoplastisch, antineoplastic, 抗新生物性
-
2024,
Yao Y, Zhang X, Ge R, Im HS, Yao C
Zhongguo Zhen Jiu 44 (12): 1388-1394
-
2024,
Hernandez D, Nam T, Lee E, Lee JJ, Kim K, Kim KN
PLoS One 19 (10): e0312343
-
2024,
Eydelkhani M, Kiabi S, Nowruzi B
BMC Biotechnol 24: 27
-
2024,
Rana JN, Mumtaz S, Han I, Ha Choi E
Free Radic Biol Med 225: 221-235
-
2024,
Zhong S, Zhang Z, Zhao Q, Yue Z, Xiong C, Chen G, Wang J, Li L
Nat Commun 15: 8097
-
2024,
Ma J, Singh S, Li M, Seelig D, Molnar GF, Wong ET, Dhawan S, Kim S, Helland L, Chen D, Tapinos N, Lawler S, Singh G, Chen CC
Neurooncol Adv 6 (1): vdae121
-
2024,
Lucia U, Bergandi L, Grisolia G, Fino D, Mareschi K, Marini E, Santa Banche Niclot AG, Tirtei E, Asaftei SD, Fagioli F, Ponzetto A, Silvagno F
Biomed Pharmacother 177: 117162
-
2024,
Cao X, Li J, Ren J, Peng J, Zhong R, He J, Xu T, Yu Z, Jin H, Hao S, Liu R, Xu B
EMBO Mol Med 16 (7): 1704-1716
-
2024,
Amirinejad M, Eftekhar-Vaghefi SH, Nematollahi-Mahani SN, Salari M, Yahyapour R, Ahmadi-Zeidabadi M
Curr Radiopharm 17 (1): 55-67
-
2024,
Cao Q, Hajosch A, Kast RE, Loehmann C, Hlavac M, Fischer-Posovszky P, Strobel H, Westhoff MA, Siegelin MD, Wirtz CR, Halatsch ME, Karpel-Massler G
Br J Cancer 130 (8): 1365-1376
-
2023,
Koshida T, Maruta T, Tanaka N, Hidaka K, Kurogi M, Nemoto T, Yanagita T, Takeya R, Tsuneyoshi I
Acta Med Okayama 77 (4): 359-364
-
2023,
Fishman H, Monin R, Dor-On E, Kinzel A, Haber A, Giladi M, Weinberg U, Palti Y
J Neurooncol 163 (1): 83-94
-
2023,
Tian X, Wang C, Yu B, Fan Y, Zhang L, Zhang X
Eur J Nucl Med Mol Imaging 50 (2): 314-327
-
2022,
Shibaki R, Kakikawa M
Electromagn Biol Med 41 (3): 343-351
-
2022,
Wang M, Yin Y, Yang H, Pei Z, Molassiotis A
Eur J Oncol Nurs 58: 102124
-
2021,
Baghban R, Afarid M, Soleymani J, Rahimi M
Biomed Pharmacother 144: 112321
-
2021,
Hack SJ, Kinsey LJ, Beane WS
Int J Mol Sci 22 (20): 11159
-
2021,
Rasheed S, Rehman K, Akash MSH
Biomed Pharmacother 143: 112119
-
2021,
Liu S, Shi W, Zhao Q, Zheng Z, Liu Z, Meng L, Dong L, Jiang X
Biomed Pharmacother 141: 111810
-
2021,
Dehghani-Soltani S, Eftekhar-Vaghefi SH, Babaee A, Basiri M, Mohammadipoor-Ghasemabad L, Vosough P, Ahmadi-Zeidabadi M
Cancer Biother Radiopharm 36 (7): 579-587
-
2020,
Ghiaseddin AP, Shin D, Melnick K, Tran DD
Curr Treat Options Oncol 21 (9): 76
-
2020,
Tan AC, Ashley DM, López GY, Malinzak M, Friedman HS, Khasraw M
CA Cancer J Clin 70 (4): 299-312
-
2020,
Paulides MM, Trefna HD, Curto S, Rodrigues DB
Adv Drug Deliv Rev 163-164: 3-18
-
2020,
Rageh MM, El-Garhy MR, Mohamad EA
Naunyn Schmiedebergs Arch Pharmacol 393 (8): 1475-1485
-
2020,
Lu CH, Kuo YY, Lin GB, Chen WT, Chao CY
PLoS One 15 (1): e0222126